Alexander Hardy insider trades
Open-market stock purchases and sales by Alexander Hardy, Chief Executive Officer at Biomarin Pharmaceutical Inc, from SEC Form 4 filings since Dec 1, 2023.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 17, 2026 | BMRN Biomarin Pharmaceutical Inc | Sold (not open market) | $238K |
| Mar 16, 2026 | BMRN Biomarin Pharmaceutical Inc | Bought (not open market) | — |
| Mar 16, 2026 | BMRN Biomarin Pharmaceutical Inc | Bought (not open market) | — |
| Mar 13, 2026 | BMRN Biomarin Pharmaceutical Inc | Sold (not open market) | $172K |
| Dec 1, 2025 | BMRN Biomarin Pharmaceutical Inc | Sold (not open market) | $912K |
Companies traded
- BMRN Biomarin Pharmaceutical Inc: other filings, last Mar 17, 2026